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transredial approach (2 patients) was used to implant elents through 6 or 8 
French guiding catheters in 22 vessels (7 LAD, 5 RCA, 5 circumflex, 3 left 
main, 1 obtuse marginal, 1 SVG); 10 vessels had bifurcations at the site, and 
11 had > 45 Q curvature. Prepmcedure minimum lumen diameter (MLD) was 
1,1 4- 0,3 ram, diameter elenosis was 82 4- 7%, and lesion length was 31 4-17 
mm (16 to 66 ram). All sterile were successfully deployed at the intended site; 
4 vessels received multiple GR II stents (maximum 3). The post-stent MLD 
was 3,2 4- 0.5 rnm, with a residual stanosis of 3 ± 3%. Pest-precedure therapy 
for 17 patients consisted Of ticlopidine for 1 month and aspidn indefinitely; 1 
patient with atdal tibdllation received systemic anticoagulalion. No subacute 
thrombOses, deaths, myocardial infarctions, or repeat inte~ventioes occurred 
within the first 3 monlhs of clini~l follow-up. Conclusion: The new features 
facilitate slant placement compared to the currently available system initial 
clinical results appear promising. 
~ L a t e  Clinical end Ang iograph ic  Outcome of Bai lout 
Coronary Slanting. A Compar ison Study Between 
GianturomRoub|n and Palmaz-Schatz Stents 
Antonio Fem~zndez-Ortiz, Javier Goicolea, Maria J. Perez-Vizcayno, 
Femando AffonsO, Resana Hern~ndez, Camino Baeuelos, Javier Segev~, 
Adelfu Rediguez, Cadcs IVlacaya. Hospital Univ. San Carlos, Madrid, Spain 
Coronary stsnti~lg provides a rapidly applied nonsurgical alternative to uor- 
rect asute di6sections following unsuccessful balloon ang!oplasty. Although a 
variety of stents have been shown to be useful in this situation, the influence 
that the atent design may have in long-term OutCO~ ,s remains uncertain. 
In the prose~Jl study, 34 consecutive pts receiving a Gi~turce-Roubin (GR) 
stant were matched to 34 pts receiving a Palmaz-Schalz (PS) stant. Pts ware 
elegible if they had undergone successful coronary sterr~'~g for acute dissec- 
tion following balloon angiuplaely and a 6-month control angingraphic study 
had been pedormed. Group matching was performed according to vessel 
size (reference diameter [REID] by quantitative computerized angiography 
[QCA]), location of target lesion and dissection type (ALIA classification). 
FelloW-up clinical data (% free of cardiac death, revasculaJ~.ation and my- 
ocardial infarction [Ev-free]) and QCA angiographic follow-up data (late loss 
and minimal luminal diameter [MLDfu l, and % of restenosis ~ > 5(P/~ 
[Re]) were compared (X + SD): 
GR PS p value 
RefD (turn) 2.9 • 0.4 2.0 4- 0.4 ns 
Dissection length imm) 10.1 ~: 8.2 19.7 ± 5.7 ns 
MID post-slant (ram) 2.4 4- 0.5 2.5:1:0.5 ns 
MID fol~w-up (ram) 1.3 + 0.9 1.8 :~ 0.7 <0.05 
MID late loss (ram) 1.1:1:0.8 0.7 :l: 0.6 < 0.05 
Re (%) 15 i44%) 5 (15°/=) <0.05 
Ev-free (%) 24 (70%) 28 (85%) <0.05 
Conclusions: PS stenting for the management of acute coronary dissec- 
tions after angioplasty provides a better clinical outcome than GR stenting. 
This benefit is mainly determined by a lower late loss resulting in larger 
luminal diameter at 6-month fdilow-up with PS stenting. 
~ Serial After Cordis Stent Angiogrsph lo  Fol low-up 
Implantation. m Compar ison  With Palmaz.Sohatz 
Stent 
Naoya Hamaseki, Hideyuki Nosaka, Takeshi Kimura, Masakiyo NobuyoshL 
Kitakyushu, Kokura Memorial Hospital, Japan 
The purpose of the present study was to evaluate progress of restenosis 
after successful Cordis (CD) stent placement and to compare it with Palmaz- 
Schatz(PS) efant placement by matched lesion analysis, From Jan.'94 to 
Feb.'95, CD slant plaCement was attempted in 92 consecutive patients(pts) 
with 94 lesions(Is) and successful single stent placement was achieved in 65 
pts. with 68 Is, Prospective sedal angiographic follow-up(F/U) was scheduled 
for next day, 1 month, 3 and 6 months after procedure. F/U angiogrem was 
completed in 60 lots, with 61 Is. Matching process was based on stenosis 
loCation, reference diameter (<_ 0.3 mm) and minimal umen diameter (MLD 
< 0.1 mm). All 61 Is. were matched identically selected from 586 consecutive 
sedes of successful P/S stsnt plaeereent (Feb.'g0-June'94). 
CD PS 
Reference diameter (ram) 3.144-0.44 3.14-;-0.44 NS 
MLD pre (ram) 1.04 + 0.29 0.99 ± 0.28 NS 
MLD post (ram) 2.81 ± 0.29 2.89 ± 0.35 NS 
MLD FlU (ram) 1.944- 0.5B 1.99 ± 0.66 NS 
Relative gain 0.574-0.11 0.61:1:0.13 NS 
Relative [sss 0.28 4- 0.19 0.29:1:0.21 NS 
In conclusion, although ;here was more complicated and restenotic lesions 
in CD slant group, renan'owing process didn't differ between groups in this 
relatively a small number of cohort. 
Angioplasty and Restenosls: Clinical 
Monday, March 25, 1996, 3:00 p.m.-5:00 p.m, 
Orange County Convention Center, Hall E 
Presentation Hour: 4:00 p.m,-5:00 p.m. 
• Mechanism of  Restenoais Fol lowing StenUng o! 
Renal Arter ies With Nonarticulated Palmaz Stents 
Sandeep Khosla, Dinesh Shaw, Nancy McCarthy, Tyrone J. Collins, J. 
Stephen Janldns, Chnstepher J. White, Stephen R. Ramee. Ochsner Clinic, 
New Orleans LA 
To investigate the mechanism of restenosis following renal artery stenting, 
computer-assieled quantitative angiogmphic measurements were made at 
the proximal, middle and distal segments of the slant in 57 renal arteries 
treated with nonadiculated Palmaz " stants in 41 patients (28 male, 13 
female, mean age 66 years; range 37 to 84 years). Identical measurements 
were repeated at 6 month angiographic foflow-up {mean 255 ± 240 days). 
Mean reference vessel diameter (RVD) at baseline, post stent and at 6 
months was 5.1 ~ 1.2, 5.1 -4- 1.2 and 4.9 ± 1.2 mm respectively (p = NS). 
Mean minimum luminal diameter (MLD) at basefirre, post slanting and at 6 
months was 1.2 4- 0.6, 4.9 :E 1.1 and 3.3 ± 1.2 mm respectively (p < 0.0001 
versus baseline). 
Prox. (ram) Middle (ram) Distal (ram) 
MLD post-stenting 4.7 :t: 0.9 4.9 4-1.0 4.7 :t: 0.9 
MID at 6 months 3.6 :~ 1.0 ~ 3.7 • 1.1 ° 3.7 ± 1.1" 
Lumen loss at 6 monks 1.2 ± 0.7 1.2 :t: 1.0 1.2 ± 0.8 
Stent diameter post-slanting 5.4 :~ 0.7 5.3 ~: 0.7 5.3- 0.7 
Slant diameter St 6 months 4.9 :E 0.71" 4.8 --. 0.61, 4.8 ± 0.7 t
Slant recoil at 6 months 0.5 d: 0.4 0.4 ~- 0.3 0.3 4- 0.4 
Slant recoil in .dex t 41% 33% 25% 
$5tent rats, index = (stem recoil at 6 months + lumen loss at 6 months), *p < 0.001 
verSus MID post-slanting, tp < 0.001 versus Stent diameter post-=lentJng 
Stent diameter at 6 month follow-up was smaller than immediately post- 
stsnting suggesting that restenosiS is due to a combination of elant recoil and 
tissue ingrowth in these patients. Condusfon: Late lumen loss following stent 
deployment in the renal artsdes is predominantly due to tissue ingrowth. 
There is, however, significant stent recoil at 6 months which also contributes 
to the late lumen loss. 
~ Apalipoprotein Isoform and Upoprotein(a) as E
Risk FactOrs for  Restenosis Al ter  Coronary  
Angiop lasty  
Hideya Yamamoto, Michinod Imazu, Takashi Yamabe, Takehiko Watanabe, 
Hironod Ueda, Koichi Ono, FutoShi Tadehara, Michio Yamakido, 
Yasuhiko Hayeshi. Himshima University, Hiroshima, Japan 
We previously repoded serum level of tipoproteln(a) [Lp(a)] was a dsk fac- 
tor for restenosis. To evaluate that apolipopmtein E (apsE) isoform which 
predisposes to premature coronary artery disease also has any predictive 
value for restenosis, 103 patients (age; 63.3 4- 9.7) who underwent elective 
PTCA were available for analysis. The quantitative analysis of the stenotJc 
coronary segments was carded Out. RestenoSts was defined as the presence 
of > 50% Stenesis at follow-up. Lp(a) was measured before PTCA. APSE 
phenotypes were determined by isoelectdc focusing and classitied into three 
categories; E2 (E2/2, E2/3), E3 (E3/3), E4 (E4/4, E4/3). Results:The median 
level of serum Lp(a) was 25.7 mg/dl in patients with restenosis (N = 50) 
compared with 21.1 mg/dl in those without restenosis (N = 53) (p < 0.05). 
The restenosis rate was significantly higher in patients with Lp(a) levels > 
30 mg/dl (N : 32) ~ in those with Lp(a) levels > 30 mg/dl (N = 71) (66% 
vs, 39%, p < 0.02). SanJm lipide and incidence of restenosis in patients with 
three apo E were as follows. One subject of F.2/4 was excluded. 
E2(N =5) E3(N=81) E41N = 16) 
T. (:hal. (mg/dl) 184.6 208.7 217.3 ns 
Lp{a) (mg/dl) 22.8 24.2 17.8 ns 
RestenoSis 1 (20%) 39 (46%) 11 (e7%} ns 
Lp(s} < ,"~1 mg/dl (N = 70) iN=S) (N = 54) (No 11) 
Restenosis 1 (20%) 18 (33%) 9 (82%) p < 0.02 
I.p(a) _> 3U mg/dl (N = 32) IN = 0) (N = 27) i N = 5) 
Restenosis 19 ('/1%) 2 (40%) ns 
Multiple regression analysis adjusted for age, gender, and totelcholesfeml 
revealed that Lp(a) and apsE4 were related with restenosis. Lp(a) (10 moJdi) 
(1.52; 1.15-2.10, p < 0.01), apoE4 (1,84; 1.04-3.82, p < 0.05), (Odd ratio; 
95% confidence interval, p value). Conclusions: Elevated levels of serum 
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Lp(a) is a dsk factor of restenoSis. Ape E isoform may also contribute to 
restenosis. The highest rate of restenosis is seen in patients with apoE4, 
especially in patients with low levels of Lp(a). 
~ Early Luminal Deterioration After Successful 
Coronary Balloon Angioplssty: Insights Into the 
Me©hanisms From Cor,mary Tissue Analysis 
Pedro R. Moreno, John T. Fallo~, Vic~or E~mardi, Nell J, Wei.qsman, 
Valentin Fuster, Affredo Reddguez, igor R Pa;asios. Massachusetts General 
Hospital, Boston, MA; Mount Sinai Medical Center, New York, NY 
Early loss of minimal luminal diameter (MLD) > 0.3 mm after successful 
PTCA is associated with a higher incidence of restenosis. The mechanism 
of early loss is unknown. To test the hypothesis that thmmbus plays a signif- 
icant role in early loss, we performed a prospective study using quantitative 
computerized planimetry on coronary tissue specimens obtained by direc- 
tional atherectomy (DCA) of 24 lesions with early loss occurring 22 -4- 2 
minutes after successful PTCA, MLD and diameter stenoals were (mean ± 
SEM): 0.6 :E 0,06 mm and 76 =b 2% pro PTCA; 1.9 :E 0.9 mm and 92 ± 2% 
post-PTCA; 0.98 + 0.1 mm and 67 :E 3% pre-DCA (time of early loss); and 
2.49 ± 0.1 mm and 24 4- 4=/0 post DCA (P = 0.001). Plaque composition 
included: thrombUs: 6 ± 0.4%, sclerotic tissue: 63:1: 6%, fibrocellular tissue: 
16:1: 4=/0, hypemellutar tissue: 12 ~: 3°/0, and athemmatous gruel: 3 :E 0.1%. 
Thrembus was present in only 9/24 (37%) lesions. Furthermore, relative arly 
10ss index ((MLD post-PTCA MLD - MID at early loss/Reference Diameter) 
x 100} was similar in plaques with or without hromhus, 35 4- 7=/0 vs 26 ± 
2% respectively (P = 0.87). Linear regression analysis showed no relation 
between thrombUs and early loss (r = 0,004, P = 0.76). 
Conclusion: Histopathologic analysis of lesions with early luminal loss 
following PTCA showed that thrombus does not pIW a significant role in this 
eady angiographic phenomenon. 
~ A  Sensit ive and Cost-Effective Intrevascular 
Ultrasound Model to Study Anti-Rsstenssis 
Strategies In Vivo 
Gary S. Mtntz, Roxana Mehran, Mun K. Hong, Jeffrey J, Popma, Augusto 
D. Pichard, Lowell F. Satier, Kenneth M. Kent, N. V. Oat, Martin B. Leon. 
Washington Hospital Center, Washington, DC 
STRESS and BENESTENT showed that stents reduce restenosis, but re- 
quired sample sizes in excess of 200 Its per arm to demonstrate a 30% 
reduction in restenosis rates, TO develop a more sensitive model for detecting 
reductions in restenoSis rates, we used volumetric Intravascular ultrasound 
(IVUS: motorized transducer pullback 0.5 ram/sac through a stationary 
imaging sheath) to analyze instant restenosis 1 month after implantation 
of single Palma-Schatz slants into 37 porcine coronary artafias and 3.5 
1.7 months after implantation of single Palmaz-Schatz Stsnts into 30 native 
human coronary arteries. Stent and lumen areas were measured in 1 mm 
axial incrsaments; intimal hyperplasia (IH = stent - lumen) area; and slant, 
lumen, and IH volumes (vol, mm ~) were calculated using Simpson's rule. 
Calculated sample sizes (in each arm) required to demonstrate 25% and a 
50% decreases in IH vat (~ = 0.05, 80% power) are 
Pigs Humans p 
Stsnt volume 1064-12 106 -~ 40 NS 
Lumen volume 67 4- 21 69 ~- 43 NS 
IH volume 39 4-17 3S 4- 25 NS 
# to show a 25% decrease in IH vol 49 112 
# to show a 50% decrease in IH v,~l 13 2S 
We conclude: Quantitative volumetric IVUS results in human and porcine 
coronary artedas after stent placement are virtually identical. Because smaller 
sample alzas are required to show effectiveness Of strategies to reduce In- 
stant cellular proliferation, this volumetric IVUS model should be a sensi~ve 
and therefore cost-effective method of studying rastenosis, particularly in- 
stent restenosis. 
~ A  Preliminary Report of Local Alcohol Delivery for 
Treatment of Reatenosls Within Slanted Segments 
After Su©caSsful Coronary Angloplasty. The Safety 
,'Study of Local Alcohol and Slant Against 
Restenosis (LASAR) Trial 
Ming W. Liu, Gary S. Roubin, William A. Baxley, Larry S. Dean, Srirum lyer, 
J. Michael Parks, Ranald Sutor. Intervantional Cardiology, Division of 
Card/ovascular Disease, University of Alabama at Birmingham, Birmingham 
AL 
Local delivery of pharmacological gents into the vessel wall with specially 
designed delivery catheters to prevent restenosis is being extensively invas- 
tigated. We have obeelved that local delivery alcohol solution into balloon 
injured artedal segments may significeatly reduce intimal hyperplasia in two 
animal study models, i.e., rabbit lilac artadas and pig coronary artsdes. Pa- 
tients who had successful coronary stanting and developed restenosis within 
the stented segments were enrolled In the study, The restenotic lesions are 
first completely dilated and then received 3 ml alcohol solution delivered by a 
Dispatch Catheter over 3 minutes. In our first phase (safety study), 9 patients 
were enrolled. The first 2 patients received 3 ml 2=/= alcohol solution, the 3rd 
and 4th patients received 3 ml 5% alcohol solution, the 5th and 6th patients 
received 3 m110=/= alcohol solution and the last 2 patients received 3 ml 15=/o 
alcohol solution. Lesions treated were in left antedor descending artery (n = 
1 ), left circumflex artery (n = 1), dght coronary artery (11 = 4), and ve|n graft (n 
= 2). Symptoms, 12 leads EKG and cardiac rhythms were closely monitored 
dudng, immediately and 24 hr. after the procedure. Cardiac enzyme was 
also followed every 8 hr. for 24 hr. There were n0 symptoms related to local 
alcohol delivery. No EKG or rhythm change was noted. Cardiac enzymes 
revealed no significant dss. Clinical follow-up up to 2 months has not shown 
recurrence. Coronary angiogram will be performed at 4 to 6 months in all pa- 
tients. We have nowStarted the second phase of the study in which patients 
will be treated with 3 m115% alcohol solution with a Dispatch catheter after 
angioptasty. 
~ E f l e ~  of Trenilast on Restenssis  After Coronary 
Angioplssty 
Tomoya Onodera, Akinofi Takizawa, Man-Sok Kim, Hiroyuki Fukita, 
Akihiko Uehara, Tsuyashi Urushida, Masaki Matsunaga, Takeshi Yoneda, 
Shinzo Miyarecto, Tomoyuki Kubeta. Shizuoka City Hospital, Shizuoka, 
Japan 
The effect of Trenilast (an inhibitor of tibroblast proliferation and collagen 
accumulation) on reStenosis after coronary angioptasty is still controversial. 
In this trial, 100 patients who received Tranilast (600 mg/day) after successful 
balloon angioptaaty till follow-up angiography were compared with 100 control 
patients. Coronary angiograms before angioplasty, after asgioplasty and 
at fallow-up at 4 :E 1 months were quantitatively analyzed and minimal 
lureinal diameter (MLD) was obtained. Reatenosis was defined as > 50=/o 
diameter stenosis at follow-up angiograrn, Baseline charactadstics including 
age, gender, dsk factors and lesion characteristics were similar in both 
groups. Results: Follow-up angiography was performed in 88 patients with 
Tranilast and in 85 Control patiant~. 
TranilaM Control p 
MLD pro (ram) 0.724- 0 .32  0.70:1:0.33 NS 
MLO post (ram) 1,80 ± 0.42 1,82 4- 0.48 NS 
MLD follow-up (ram) 1.34 -~ 0.65 1.39 ± 0.62 NS 
% Stenosls pro 72.1 4-10.4 73.1.4-13A NS 
% Stenosis post 29.4 4-16,5 29.7 4-18.3 NS 
% Stenosis follow-up 47.6 -I* 25,3 46.3 4- 24.2 NS 
Restanosia rare 55% (49/88) 51% (43/as) NS 
Conclusion: Tranilast at this tdal failed to reduce the incidence of resten¢> 
sis. Further study is needed before using Tranitast as an adjunctive treatment 
for the prevention of restenosis after coronary angioplasty. 
~ L o w  Expression of  Calponln in Smooth Muscle 
Cells of Coronary Artery Lesions Identifies the 
High Risk for  Rsstenosis  After Directional 
Comssry Athere~omy 
Hidemasa Oh, Macanobu Funamoto, Etsuo T6uchikase, Nobuyuki Negoro, 
Tore Kob~yashi, Kalsuhito TakahaShi, Nobuhisa Aware. The Center for 
Adult Diseases, Osaka, Osaka, Japan 
The process of coronary restenosis after angioplasty is accompanied by 
neolntimal formation, We have reported that local delivery of the recombinant 
human calpenin (CN) gane inhibits myolntimal hyperplasia in animals. Low 
levels of CN expression have been correlated with a proliferating smooth 
muscle cells (SMC) phenotype in Vitro. "io elucidate its role in human coronary 
arteries, we investigated 108 consecutive atherosalemti¢ lesions (53 de novo 
and 55 restenosis) retrieved by directional coronary atherectomy (DCA) for 
the expression of CN using immunohistochemistry. The CN expression was 
quantified by calculating the relative abundance of CN positive cells among 
the ~-actin positive cells in more than 100 nuclei in three high power fields 
(xl00). Seventy out of 108 DCA specimens were subjected to analyze and 
divided into two groups based on the ratio of CN positive cells to that of 
a-actin (C/A ratio); Gr-H (n = 42): C/A ratio > 0.6, Gr.L (n = 28): C/A ratio 
< 0,6. Coronary quantitative analysis was performed at 6 months follow-up, 
and toss index were calculated. Significant negative correlation was found 
between the levels of CN expression and loss index at 6 months follow-up (y 
= 0.936-0.698 x, r= -0.62, p < 0.0001). 
